Correlation Between Aspen Pharmacare and Impala Platinum

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aspen Pharmacare and Impala Platinum at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aspen Pharmacare and Impala Platinum into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aspen Pharmacare Holdings and Impala Platinum Holdings, you can compare the effects of market volatilities on Aspen Pharmacare and Impala Platinum and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aspen Pharmacare with a short position of Impala Platinum. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aspen Pharmacare and Impala Platinum.

Diversification Opportunities for Aspen Pharmacare and Impala Platinum

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Aspen and Impala is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Aspen Pharmacare Holdings and Impala Platinum Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Impala Platinum Holdings and Aspen Pharmacare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aspen Pharmacare Holdings are associated (or correlated) with Impala Platinum. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Impala Platinum Holdings has no effect on the direction of Aspen Pharmacare i.e., Aspen Pharmacare and Impala Platinum go up and down completely randomly.

Pair Corralation between Aspen Pharmacare and Impala Platinum

Assuming the 90 days trading horizon Aspen Pharmacare Holdings is expected to generate 0.23 times more return on investment than Impala Platinum. However, Aspen Pharmacare Holdings is 4.44 times less risky than Impala Platinum. It trades about -0.49 of its potential returns per unit of risk. Impala Platinum Holdings is currently generating about -0.27 per unit of risk. If you would invest  1,822,100  in Aspen Pharmacare Holdings on August 28, 2024 and sell it today you would lose (149,000) from holding Aspen Pharmacare Holdings or give up 8.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Aspen Pharmacare Holdings  vs.  Impala Platinum Holdings

 Performance 
       Timeline  
Aspen Pharmacare Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aspen Pharmacare Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Impala Platinum Holdings 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Impala Platinum Holdings are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, Impala Platinum exhibited solid returns over the last few months and may actually be approaching a breakup point.

Aspen Pharmacare and Impala Platinum Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aspen Pharmacare and Impala Platinum

The main advantage of trading using opposite Aspen Pharmacare and Impala Platinum positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aspen Pharmacare position performs unexpectedly, Impala Platinum can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Impala Platinum will offset losses from the drop in Impala Platinum's long position.
The idea behind Aspen Pharmacare Holdings and Impala Platinum Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk